Parliamentary Search

Written question asked by Helen Hayes (Labour) on Friday, 28 August 2026, in the House of Commons. It was due for an answer on Thursday, 3 September 2026 (named day). A holding answer was provided on Friday, 4 September 2026. A substantive answer was provided by James Frith (Labour) on Monday, 7 September 2026 on behalf of the Department of Health and Social Care.

Cardiovascular Diseases: Screening

Question

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to improve access to genetic testing for inherited lipid conditions, including familial hypercholesterolaemia, in order to initiate cholesterol management at an early stage for people at greatest risk of cardiovascular disease.

Answer

Integrated care boards (ICBs) are responsible for ensuring that people with high cholesterol or an increased risk of cardiovascular disease (CVD) receive treatment in line with recommended targets. Published on 7 July 2026, the CVD Modern Service Framework identifies improved cholesterol detection and management, for people with and without existing CVD, among the 12 priorities supporting the Government’s ambition to reduce premature deaths from heart disease and stroke by 25% within a decade.

For each of the priorities, it brings together national standards, key metrics, and delivery ambitions over three and 10 year horizons to drive implementation locally and narrow variation across the country.

ICBs are responsible for identifying and managing inherited lipid conditions, including familial hypercholesterolaemia, in line with National Institute for Health and Care Excellence guidance and with support from national genetic testing services.

Secondary information

Type
Written question
Reference
21276
Session
2026-27
Grouped for answer
Yes
Subjects
Screening Cardiovascular diseases Cholesterol
Link
View this Written question on www.parliament.uk